Patents by Inventor Joel Tocker

Joel Tocker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-17 receptor A antigen binding proteins
    Patent number: 9096673
    Abstract: The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: August 4, 2015
    Assignee: KIRIN-AMGEN, INC.
    Inventors: Joel Tocker, Jacques J. Peschon, James F. Smothers
  • Anti-IL-17 receptor A neutralizing antibodies
    Patent number: 9073999
    Abstract: The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and the antigen binding proteins, such as antibodies, that bind thereto and inhibit IL-17 ligand family members from binding to and activating IL-17 Receptor A or a receptor complex comprising IL-17 Receptor A.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: July 7, 2015
    Assignee: KIRIN-AMGEN, INC.
    Inventors: Joel Tocker, Christopher Mehlin, Ai Ching Lim
  • Methods of treating psoriasis using IL-17 receptor A antibodies
    Patent number: 8790648
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: July 29, 2014
    Assignee: Amgen Inc.
    Inventors: Joel Tocker, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • Polynucleotides encoding IL-17 receptor A antigen binding proteins
    Patent number: 8545842
    Abstract: The present invention relates to IL-17 receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, and the polynucleotide sequences encoding them, as well as host cells, expression vectors, and methods of making IL-17 receptor A antigen binding proteins.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: October 1, 2013
    Assignee: Kirin-Amgen, Inc.
    Inventors: Joel Tocker, Jacques J. Peschon, James F. Smothers
  • Methods of using IL-17 receptor a antibodies
    Patent number: 8435518
    Abstract: The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.
    Type: Grant
    Filed: October 6, 2010
    Date of Patent: May 7, 2013
    Assignee: Kirin-Amgen, Inc.
    Inventors: Joel Tocker, Jacques J. Peschon, David Fitzpatrick
  • IL-17 Heteromeric Receptor Complex
    Publication number: 20130004969
    Abstract: The present invention relates to Interleukin-17 ligand and receptor family members and the discovery that IL-17 receptor A and IL-17 receptor C form a heteromeric receptor complex that is biologically active.
    Type: Application
    Filed: September 6, 2012
    Publication date: January 3, 2013
    Applicant: Amgen Inc.
    Inventors: Jacques Peschon, Joel Tocker, Dean Toy
  • USE OF IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS
    Publication number: 20120308566
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for treating diseases, such as various forms of cancer.
    Type: Application
    Filed: October 12, 2010
    Publication date: December 6, 2012
    Inventors: David Andrew Martin, Joel Tocker, Scott Baumgartner, Donna Christine Franko
  • IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS
    Publication number: 20120251547
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
    Type: Application
    Filed: May 15, 2012
    Publication date: October 4, 2012
    Applicant: Amgen, Inc.
    Inventors: Joel TOCKER, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS
    Publication number: 20110166331
    Abstract: The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.
    Type: Application
    Filed: March 10, 2011
    Publication date: July 7, 2011
    Applicant: Amgen, Inc.
    Inventors: Joel TOCKER, Jacques J. Peschon, James F. Smothers
  • IL-17 receptor A antigen binding proteins
    Patent number: 7939070
    Abstract: The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: May 10, 2011
    Assignee: Amgen Inc.
    Inventors: Joel Tocker, Jacques J. Peschon, James F. Smothers
  • METHODS OF USING IL-17 RECEPTOR A ANTIBODIES
    Publication number: 20110081339
    Abstract: The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.
    Type: Application
    Filed: October 6, 2010
    Publication date: April 7, 2011
    Applicant: AMGEN INC.
    Inventors: JOEL TOCKER, JACQUES J. PESCHON, DAVID FITZPATRICK
  • IL-17 HETEROMERIC RECEPTOR COMPLEX
    Publication number: 20110008356
    Abstract: The present invention relates to Interleukin-17 ligand and receptor family members and the discovery that IL-17 receptor A and IL-17 receptor C form a heteromeric receptor complex that is biologically active.
    Type: Application
    Filed: June 13, 2008
    Publication date: January 13, 2011
    Applicant: AMGEN, INC.
    Inventors: Jacques J. Peschon, Joel Tocker, Dean Toy
  • POLYNUCLEOTIDES ENCODING IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS
    Publication number: 20110008841
    Abstract: The present invention relates to IL-17 receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, and the polynucleotide sequences encoding them, as well as host cells, expression vectors, and methods of making IL-17 receptor A antigen binding proteins.
    Type: Application
    Filed: June 25, 2010
    Publication date: January 13, 2011
    Applicant: Amgen Inc.
    Inventors: Joel TOCKER, Jacques J. Peschon, James F. Smothers
  • ANTI-IL-17 RECEPTOR A NEUTRALIZING ANTIBODIES
    Publication number: 20100292442
    Abstract: The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and the antigen binding proteins, such as antibodies, that bind thereto and inhibit IL-17 ligand family members from binding to and activating IL-17 Receptor A or a receptor complex comprising IL-17 Receptor A.
    Type: Application
    Filed: May 21, 2010
    Publication date: November 18, 2010
    Applicant: AMGEN , INC.
    Inventors: JOEL TOCKER, CHRISTOPHER MEHLIN, AI CHING LIM
  • Methods of treating psoriasis using IL-17 Receptor A antibodies
    Patent number: 7833527
    Abstract: The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: November 16, 2010
    Assignee: Amgen Inc.
    Inventors: Joel Tocker, Jacques J. Peschon, David Fitzpatrick
  • Polynucleotides encoding IL-17 receptor A antigen binding proteins
    Patent number: 7786284
    Abstract: The present invention relates to IL-17 receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, and the polynucleotide sequences encoding them, as well as host cells, expression vectors, and methods of making IL-17 receptor A antigen binding proteins.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: August 31, 2010
    Assignee: Amgen Inc.
    Inventors: Joel Tocker, Jacques J. Peschon, James F. Smothers
  • Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
    Patent number: 7767206
    Abstract: The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and the antigen binding proteins, such as antibodies, that bind thereto and inhibit IL-17 ligand family members from binding to and activating IL-17 Receptor A or a receptor complex comprising IL-17 Receptor A.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: August 3, 2010
    Assignee: Amgen Inc.
    Inventors: Joel Tocker, Christopher Mehlin, Ai Ching Lim
  • IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS
    Publication number: 20100028345
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation by one or more IL-17 ligands. The present invention relates to the identification of neutralizing determinants on IL-17 Receptor A (IL-17RA or IL-17R) and antibodies that bind thereto. Aspects of the invention also include antibodies that compete for binding with the IL-17RA neutralizing antibodies described herein.
    Type: Application
    Filed: October 1, 2007
    Publication date: February 4, 2010
    Applicant: AMGEN INC.
    Inventors: Joel Tocker, Jacques J. Peschon, David Fitzpatrick, James F. Smothers, Christopher Mehlin, Ai Ching Lim
  • IL-17 receptor a antigen binding proteins
    Publication number: 20090074758
    Abstract: The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and compositions and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.
    Type: Application
    Filed: September 28, 2007
    Publication date: March 19, 2009
    Applicant: Amgen, Inc,
    Inventors: Joel Tocker, Jacques J. Peschon, James F. Smothers
  • Methods of using IL-17 receptor A antibodies
    Publication number: 20080219979
    Abstract: The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.
    Type: Application
    Filed: September 27, 2007
    Publication date: September 11, 2008
    Applicant: Amgen Inc.
    Inventors: Joel Tocker, Jacques J. Peschon, David Fitzpatrick